Latest filing published 13 Dec 2016 for Armata Pharmaceuticals, Inc., €2,570.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -74.5%Entry US$802.20 · Close at T+365 US$204.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Michael Scott Salka: trading record in brief
Michael Scott Salka appears in our data through filings on Armata Pharmaceuticals, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 5 October 2015 to 9 December 2016.
The open-market record is one-sided, with 1 purchase worth €18k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
Most recently, on 13 December 2016, the filings show a share grant worth €2,570 in Armata Pharmaceuticals, Inc. The last insider purchase was made public on 6 October 2015, 4,052 days ago. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michael Scott Salka
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,000 shares@ US$0.39100.0% of flowCommon StockSEC:0001209191-16-154877:0
- 4,200 shares@ US$4.75Common StockSEC:0001209191-15-074438:0Canonical exit: 3 Jan 2016 (T+90)
2 of 2 declarations